97 items matching your search terms.

Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD study

Cao, J. Y. Waldman, B. O'Connell, R. Sullivan, D. R. Scott, R. S. Aryal, N. Gebski, V. Marschner, I. Taskinen, M. R. Simes, J. R. McGill, N. Jenkins, A. J. Keech, A. C. Field investigators
DIABETES, OBESITY AND METABOLISM, 2020     DOI:10.1111/dom.14046

Recurrent time-to-event models with ordinal outcomes

Gebski, V. Byth, K. Asher, R. Marschner, I.
PHARMACEUTICAL STATISTICS, 2020     DOI:10.1002/pst.2057

Efficacy of immune checkpoint inhibitors in older adults with advanced stage cancers: A meta-analysis

Kasherman, L. Siu, D. H. W. Lee, K. W. C. Lord, S. Marschner, I. Lewis, C. R. Friedlander, M. Lee, C. K.
J GERIATR ONCOL, 2020     DOI:10.1016/j.jgo.2019.05.013

Validation of progression-free survival rate at 6 months and objective response for estimating overall survival in immune checkpoint inhibitor trials: a systematic review and meta-analysis

Kok, P. S. Cho, D. Yoon, W. H. Ritchie, G. Marschner, I. Lord, S. Friedlander, M. Simes, J. Lee, C. K.
JAMA NETW OPEN, 2020     DOI:10.1001/jamanetworkopen.2020.11809

The impact of smoking on the effectiveness of immune checkpoint inhibitors - a systematic review and meta-analysis

Lee, K. W. C. Lord, S. J. Kasherman, L. Marschner, I. Stockler, M. Gralla, R. Yang, J. C. Mok, T. Lee, C. K.
ACTA ONCOLOGICA, 2020     DOI:10.1080/0284186X.2019.1670354

Sensitivity analyses assessing the impact of early stopping on systematic reviews: Recommendations for interpreting guidelines

Marschner, I. C. Askie, L. M. Schou, I. M.
RES SYNTH METHODS, 2020     DOI:10.1002/jrsm.1394

Back-projection of COVID-19 diagnosis counts to assess infection incidence and control measures: analysis of Australian data

Marschner, I. C.
EPIDEMIOLOGY AND INFECTION, 2020     DOI:10.1017/S0950268820001065

Benchmarking single-arm studies against historical controls from non-small cell lung cancer trials - an empirical analysis of bias

Snyders, K. Cho, D. Hong, J. H. Lord, S. Asher, R. Marschner, I. Lee, C. K.
ACTA ONCOLOGICA, 2020     DOI:10.1080/0284186X.2019.1674452

Changes in plasma lipids predict pravastatin efficacy in secondary prevention

Jayawardana, K. S. Mundra, P. A. Giles, C. Barlow, C. K. Nestel, P. J. Barnes, E. H. Kirby, A. Thompson, P. Sullivan, D. R. Alshehry, Z. H. Mellett, N. A. Huynh, K. McConville, M. J. Zoungas, S. Hillis, G. S. Chalmers, J. Woodward, M. Marschner, I. C. Wong, G. Kingwell, B. A. Simes, J. Tonkin, A. M. Meikle, P. J. Lipid Study Investigators
JCI INSIGHT, 2019     DOI:10.1172/jci.insight.128438

Biostatistics: a fundamental discipline at the core of modern health data science

Lee, K. J. Moreno-Betancur, M. Kasza, J. Marschner, I. C. Barnett, A. G. Carlin, J. B.
MEDICAL JOURNAL OF AUSTRALIA, 2019     DOI:10.5694/mja2.50372

Pulse oximeter saturation targeting and oximeter changes in the benefits of oxygen saturation targeting (BOOST)-II Australia and BOOST-II UK oxygen trials

Stenson, B. J. Donoghoe, M. Brocklehurst, P. Davis, P. G. Juszczak, E. Marschner, I. C. Simes, J. Tarnow-Mordi, W. O.
JOURNAL OF PEDIATRICS, 2019     DOI:10.1016/j.jpeds.2018.08.033

Evaluation of phase II trial design in advanced pancreatic cancer

Tang, M. Chen, J. Goldstein, D. Links, M. Lord, S. Marschner, I. Simes, R. J. Lee, C. K.
PANCREAS, 2019     DOI:10.1097/MPA.0000000000001429

Predictive value of PD-L1 and other clinical factors for chemoimmunotherapy in advanced non-small-cell lung cancer

Woodford, R. Loh, Y. Lee, J. Cooper, W. Marschner, I. Lewis, C. R. Millward, M. Lord, S. Gralla, R. J. Yang, J. C. Mok, T. Lee, C. K.
FUTURE ONCOLOGY, 2019     DOI:10.2217/fon-2019-0105

The value of early depth of response in predicting long-term outcome in EGFR-mutant lung cancer

Lee, C. K. Lord, S. Marschner, I. Wu, Y. L. Sequist, L. Rosell, R. Fukuoka, M. Mitsudomi, T. Asher, R. Davies, L. Gebski, V. Gralla, R. Mok, T. Chih-Hsin Yang, J.
JOURNAL OF THORACIC ONCOLOGY, 2018     DOI:10.1016/j.jtho.2018.03.010

Underestimation of treatment effects in sequentially monitored clinical trials that did not stop early for benefit

Marschner, I. C. Schou, I. M.
STATISTICAL METHODS IN MEDICAL RESEARCH, 2018     DOI:10.1177/0962280218795320